Bristol Myers faces renewed, $6.7 bln lawsuit over delayed cancer drug | Reuters

… cancer drug Breyanzi, by specified deadlines. It said Bristol Myers did this to avoid a big payout. On Sept. 30, U.S. District Judge Jesse Furman …